Detalhe da pesquisa
1.
LSD1 in drug discovery: From biological function to clinical application.
Med Res Rev;
44(2): 833-866, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38014919
2.
LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy.
J Biomed Sci;
30(1): 60, 2023 Jul 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37525190
3.
Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness.
EMBO Rep;
22(8): e50922, 2021 08 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34060205
4.
Generation, secretion and degradation of cancer immunotherapy target PD-L1.
Cell Mol Life Sci;
79(8): 413, 2022 Jul 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35819633
5.
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer.
Mol Cancer;
21(1): 75, 2022 03 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35296335
6.
The design, synthesis and cellular imaging of a tumor-anchored, potent and cell-permeable BRD4-targeted fluorescent ligands.
Bioorg Chem;
114: 105120, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34216895
7.
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.
Bioorg Chem;
116: 105273, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34474304
8.
Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Med Res Rev;
40(5): 1920-1949, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32391596
9.
LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9.
Pharmacol Res;
159: 104991, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32504836
10.
Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation.
Bioorg Chem;
97: 103648, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32065882
11.
USP28 contributes to the proliferation and metastasis of gastric cancer.
J Cell Biochem;
120(5): 7657-7666, 2019 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30485491
12.
Identification of osimertinib (AZD9291) as a lysine specific demethylase 1 inhibitor.
Bioorg Chem;
84: 164-169, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30502627
13.
Sanggenon O induced apoptosis of A549 cells is counterbalanced by protective autophagy.
Bioorg Chem;
87: 688-698, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30953888
14.
Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803.
J Cell Biochem;
119(6): 4957-4966, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29384217
15.
LPE-1, an orally active pyrimidine derivative, inhibits growth and mobility of human esophageal cancers by targeting LSD1.
Pharmacol Res;
122: 66-77, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28571892
16.
Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation.
Bioorg Med Chem Lett;
27(22): 5036-5039, 2017 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29037950
17.
1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors.
Cell Physiol Biochem;
38(1): 185-93, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26784898
18.
Baicalin, a natural LSD1 inhibitor.
Bioorg Chem;
69: 129-131, 2016 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27814566
19.
A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors.
Med Res Rev;
35(5): 1032-71, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25990136
20.
Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents.
Bioorg Med Chem Lett;
25(5): 1124-8, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25655718